Loring Wolcott & Coolidge Fiduciary Advisors’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
ACH
Loring Wolcott & Coolidge Fiduciary Advisors's TBI Position: Q1 2022 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Trueblue (TBI) in Q1 2022, closing a stake of 384 shares — an estimated $11K sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in TBI in Q4 2020 and held it in 4 quarters. The position peaked at $11K in Q4 2021. 183 funds tracked by Wall St. Rank hold TBI as of Q1 2022.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Trueblue position as of Q1 2022 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 384 Trueblue shares in Q1 2022, an estimated $11K.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Trueblue in Q4 2020 and held it in 4 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's Trueblue position peaked at $11K in Q4 2021.
- 183 funds tracked by Wall St. Rank held Trueblue as of Q1 2022.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2022, filed 13 Apr 2022.